Tarik Skubal, Cam Schlittler, Cristopher Sanchez and Paul Skenes are among the projected two-start pitchers for the upcoming ...

D1 Capital Partners continues to beat its peers. The hedge fund’s public portfolio gained 4.4 percent in April and is now up 11.8 percent for the year, according to a source who has seen the results.

Crypto traders are currently pricing the SpaceX pre-IPO perpetual future on Hyperliquid at around $162, about 20% above the company's fixed IPO price of $135 per share. The so-called perp is down ...

A category of exchange-traded funds offering eye-catching coupons is creating buzz among the income-seeking set, but investors who want to dabble in these offerings should prepare to do their homework ...

Wall Street is mistaken to insist that the bull market can’t be in danger because corporate earnings are growing fast. Blistering earnings growth of the kind that S&P 500 SPX companies have been ...

Watch double digit bass explode on bait during a feeding frenzy captured in real time with Livescope recording. Coffee found to have startling effect on aging, says new study He was fooling around on ...

BOSTON (SHNS) – Nearly 700,000 Bay Staters are facing the prospect of double-digit premium increases next year as insurers struggle to handle cost pressures across the healthcare landscape, possibly ...

BERLIN, Conn. (WFSB) - Eversource is looking for a double digit rate hike. During a virtual meeting with reporters earlier on Tuesday, the company’s president of Connecticut operations, Steve Sullivan ...

See more of our trusted coverage when you search. Prefer Newsweek on Google to see more of our trusted coverage when you search. Democrats hold a double-digit lead over Republicans on the generic ...

Ten stocks kicked off the trading week with double-digit gains, defying a lackluster performance on the broader market, as investors turned to positive developments to bolster their buying appetite.

Johnson & Johnson has reinvented itself several times in recent years. In 2021, it was best known as the developer of a Covid vaccine. In 2023, it spun off its consumer health division to focus on ...